A UNIQUE TREATMENT FOR THE MANAGEMENT AND RAPID RELIEF OF COMMON COLD AND SINUSITIS SYMPTOMS
Nasodren®, is a nasal spray that, provides a rapid relief of common cold and sinusitis symptoms. The active substance of Nasodren®, Cyclamen europaeum extract, is of botanical in origin and is a natural agent.
Nasodren’s unique dual and unique mechanism of action leads to fast drainage of nasal mucosa and all paranasal sinuses resulting in rapid relief of cold and sinusitis symptoms.
Safety, and efficacy of Nasodren® are supported by 30 clinical trials conducted all around the world (USA, Germany, Spain, Russia etc.), including more than 2,000 patients. The results of these studies have been published in the most relevant scientific journals, among them, Rhinology, Official Organ of the International and European Rhinologic Societies, and The Laryngoscope, Official Organ of the American Laryngological, Rhinological and Otological Society.
Nasodren® is included in the European Guidelines for sinusitis treatment (European Position Paper on Rhinosinusitis and Nasal Polyps; EPOS 2012) with high level of evidence and recommendation.
Nasodren efficacy, safety, and pharmacoeconomics have been demonstrated in 30 clinical trials conducted around the world (USA, Germany, Spain, Russia, etc.) and the results have been published in the most relevant scientific journals, including Rhinology, official organ of the European Society of Rhinology and The Laryngoscope, the official publication of the American Society of Rhinology.
Results of the studies have led Nasodren to be included in the Sinusitis European Guidelines (European Position Paper on Rhinosinusitis and Nasal Polyps – EPOS 2012) with high level of evidence and recommendation.
FAST RELIEF OF SKIN INFLAMMATORY DISEASES SYMPTOMS
Lazolex® is a topical emollient gel with a soft (semi-solid) consistency, manufactured from a natural Extract of Unripe fruits of Juglans Regia and three different silicones. which have well-known emollient properties, formulated to create a mechanical barrier with the aim of providing an optimal environment to manage skin inflammations and also to produce a product with general skin softener and soothing properties.
Lazolex® is indicated to relieve itching, stinging, burning and dry skin in case of dermatitis, especially when inflammation of the skin is due to pathogens. Posology is 2-4 times a day and recommended treatment course is 10 days.
A study to test Lazolex® permeation shows penetrability enough in the epidermis for exerting its action; however, it shows a low penetrability in the dermis area above the vascular plexus, which gives it systemic therapeutic safety.
It is expected to have Lazolex® ready for marketing in Q3, 2020